{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:57:09Z","timestamp":1785603429672,"version":"3.56.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011468","name":"Foundation for Excellence in Mental Health Care","doi-asserted-by":"publisher","award":["Foundation for Excellence in Mental Health Care"],"award-info":[{"award-number":["Foundation for Excellence in Mental Health Care"]}],"id":[{"id":"10.13039\/100011468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012260","name":"Calgary Foundation","doi-asserted-by":"publisher","award":["Calgary Foundation"],"award-info":[{"award-number":["Calgary Foundation"]}],"id":[{"id":"10.13039\/100012260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029833","name":"Gratis Foundation","doi-asserted-by":"publisher","award":["Gratis Foundation"],"award-info":[{"award-number":["Gratis Foundation"]}],"id":[{"id":"10.13039\/100029833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00702-025-03086-9","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T08:21:07Z","timestamp":1767428467000},"page":"1593-1605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kynurenine metabolites unchanged after multinutrient supplementation in children with ADHD: a secondary data analysis from the MADDY study"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5929-3149","authenticated-orcid":false,"given":"Alisha M.","family":"Bruton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2521-0309","authenticated-orcid":false,"given":"Hayleigh K.","family":"Ast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1248-8723","authenticated-orcid":false,"given":"Lydia","family":"Norby-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0906-6757","authenticated-orcid":false,"given":"Priya","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-9538","authenticated-orcid":false,"given":"Lisa M.","family":"Robinette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-9088","authenticated-orcid":false,"given":"Irene E.","family":"Hatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-8086","authenticated-orcid":false,"given":"Brenda M.Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-0692","authenticated-orcid":false,"given":"L. Eugene","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-8732","authenticated-orcid":false,"given":"David","family":"Zava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3947-5540","authenticated-orcid":false,"given":"Jeanette M.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"3086_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2017.00228","author":"D Anand","year":"2017","unstructured":"Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL (2017) Attention-deficit\/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front Psychiatry. https:\/\/doi.org\/10.3389\/FPSYT.2017.00228","journal-title":"Front Psychiatry"},{"key":"3086_CR2","doi-asserted-by":"publisher","DOI":"10.15171\/ijer.2017.13","author":"M Azade","year":"2017","unstructured":"Azade M, Sazegar H, Zia-Jahromi N, Alavi-Naeini A (2017) The effects of vitamin D on kynurenine level in children with attention deficit hyperactivity disorder: an epidemiological study. Int J Epidemiol Res. https:\/\/doi.org\/10.15171\/ijer.2017.13","journal-title":"Int J Epidemiol Res"},{"key":"3086_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111890","volume":"217","author":"L Bakker","year":"2024","unstructured":"Bakker L, Choe K, Eussen SJPM, Ramakers IHGB, van den Hove DLA, Kenis G, Rutten BPF, Verhey FRJ, K\u00f6hler S (2024) Relation of the kynurenine pathway with normal age: a systematic review. Mech Ageing Dev 217:111890. https:\/\/doi.org\/10.1016\/j.mad.2023.111890","journal-title":"Mech Ageing Dev"},{"key":"3086_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.schres.2021.04.008","volume":"232","author":"F Bartoli","year":"2021","unstructured":"Bartoli F, Cioni RM, Callovini T, Cavaleri D, Crocamo C, Carr\u00e0 G (2021) The kynurenine pathway in schizophrenia and other mental disorders: insight from meta-analyses on the peripheral blood levels of Tryptophan and related metabolites. Schizophr Res 232:61\u201362. https:\/\/doi.org\/10.1016\/j.schres.2021.04.008","journal-title":"Schizophr Res"},{"issue":"7","key":"3086_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bdi.13027","volume":"23","author":"D Benevenuto","year":"2021","unstructured":"Benevenuto D, Saxena K, Fries GR, Valvassori SS, Kahlon R, Saxena J, Kurian S, Zeni CP, Kazimi IF, Scaini G, Soares JC, Quevedo J (2021) Alterations in plasma kynurenine pathway metabolites in children and adolescents with bipolar disorder and unaffected offspring of bipolar parents: a preliminary study. Bipolar Disord 23(7):689\u2013696. https:\/\/doi.org\/10.1111\/bdi.13027","journal-title":"Bipolar Disord"},{"issue":"2","key":"3086_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/MMWR.SU7102A1","volume":"71","author":"RH Bitsko","year":"2022","unstructured":"Bitsko RH, Claussen AH, Lichstein J, Black LI, Jones SE, Danielson ML, Hoenig JM, Jack D, Brody SP, Gyawali DJ, Maenner S, Warner MJ, Holland M, Perou KM, Crosby R, Blumberg AE, Avenevoli SJ, Kaminski S, Ghandour RM (2022) Mental health surveillance among children\u2014United States, 2013\u20132019. MMWR Suppl 71(2):1\u201342. https:\/\/doi.org\/10.15585\/MMWR.SU7102A1","journal-title":"MMWR Suppl"},{"issue":"5","key":"3086_CR7","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.3390\/ijms16059772","volume":"16","author":"Z Boh\u00e1r","year":"2015","unstructured":"Boh\u00e1r Z, Toldi J, F\u00fcl\u00f6p F, V\u00e9csei L (2015) Changing the face of kynurenines and neurotoxicity: therapeutic considerations. Int J Mol Sci 16(5):9772\u20139793. https:\/\/doi.org\/10.3390\/ijms16059772","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3086_CR8","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1038\/s41598-025-87546-y","volume":"15","author":"N Boonchooduang","year":"2025","unstructured":"Boonchooduang N, Louthrenoo O, Likhitweerawong N, Kunasol C, Thonusin C, Sriwichaiin S, Nawara W, Chattipakorn N, Chattipakorn SC (2025) Impact of psychostimulants on microbiota and short-chain fatty acids alterations in children with attention-deficit\/hyperactivity disorder. Sci Rep 15(1):3034. https:\/\/doi.org\/10.1038\/s41598-025-87546-y","journal-title":"Sci Rep"},{"issue":"5","key":"3086_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4088\/JCP.10m06409blu","volume":"72","author":"B Bradley","year":"2011","unstructured":"Bradley B, DeFife JA, Guarnaccia C, Phifer J, Fani N, Ressler KJ, Westen D (2011) Emotion dysregulation and negative affect: association with psychiatric symptoms. J Clin Psychiatry 72(5):685\u2013691. https:\/\/doi.org\/10.4088\/JCP.10m06409blu","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"3086_CR10","doi-asserted-by":"publisher","first-page":"21011","DOI":"10.1038\/s41598-021-99845-1","volume":"11","author":"CR Brydges","year":"2021","unstructured":"Brydges CR, Fiehn O, Mayberg HS, Schreiber H, Dehkordi SM, Bhattacharyya S, Cha J, Choi KS, Craighead WE, Krishnan RR, Rush AJ, Dunlop BW, Kaddurah-Daouk R (2021) Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature. Sci Rep 11(1):21011. https:\/\/doi.org\/10.1038\/s41598-021-99845-1","journal-title":"Sci Rep"},{"key":"3086_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","volume":"112","author":"EY Bryleva","year":"2017","unstructured":"Bryleva EY, Brundin L (2017) Kynurenine pathway metabolites and suicidality. Neuropharmacology 112:324\u2013330. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.034","journal-title":"Neuropharmacology"},{"key":"3086_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.NEULET.2016.02.016","volume":"617","author":"A B\u00fcber","year":"2016","unstructured":"B\u00fcber A, \u00c7akaloz B, I\u015fildar Y, \u00dcnl\u00fc G, Bostanci HE, Aybek H, Herken H (2016) Increased urinary 6-hydroxymelatoninsulfate levels in attention deficit hyperactivity disorder diagnosed children and adolescent. Neurosci Lett 617:195\u2013200. https:\/\/doi.org\/10.1016\/J.NEULET.2016.02.016","journal-title":"Neurosci Lett"},{"issue":"2","key":"3086_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020583","volume":"13","author":"D Cavaleri","year":"2024","unstructured":"Cavaleri D, Crocamo C, Morello P, Bartoli F, Carr\u00e0 G (2024) The kynurenine pathway in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis of blood concentrations of tryptophan and its catabolites. J Clin Med 13(2):583. https:\/\/doi.org\/10.3390\/jcm13020583","journal-title":"J Clin Med"},{"issue":"6349","key":"3086_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9794","volume":"357","author":"I Cervenka","year":"2017","unstructured":"Cervenka I, Agudelo LZ, Ruas JL (2017) Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health. Science 357(6349):eaaf9794. https:\/\/doi.org\/10.1126\/science.aaf9794","journal-title":"Science"},{"key":"3086_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2017.06.012","volume":"332","author":"J Chen","year":"2017","unstructured":"Chen J, Zhou C, Zheng P, Cheng K, Wang H, Li J, Zeng L, Xie P (2017) Differential urinary metabolites related with the severity of major depressive disorder. Behav Brain Res 332:280\u2013287. https:\/\/doi.org\/10.1016\/j.bbr.2017.06.012","journal-title":"Behav Brain Res"},{"issue":"2","key":"3086_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"A Covarrubias","year":"2021","unstructured":"Covarrubias A, Perrone R, Grozio A, Verdin E (2021) NAD\u2009+\u2009metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 22(2):119\u2013141. https:\/\/doi.org\/10.1038\/s41580-020-00313-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3086_CR17","doi-asserted-by":"publisher","unstructured":"del Mar Salmeron A, Fernandez-Martin P, Rodriguez-Herrera R, Arrabal-Campos FM, Abreu AC, Fernandez I, Flores P (2025) Urinary metabolic biomarkers of attentional control in children with Attention-Deficit\/Hyperactivity disorder: A dimensional approach through 1H NMR\u2010Based metabolomics. 38(8). https:\/\/doi.org\/10.1002\/nbm.70088","DOI":"10.1002\/nbm.70088"},{"issue":"1","key":"3086_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mehy.2013.11.018","volume":"82","author":"S Dolina","year":"2014","unstructured":"Dolina S, Margalit D, Malitsky S, Rabinkov A (2014) Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers. Med Hypotheses 82(1):111\u2013116. https:\/\/doi.org\/10.1016\/j.mehy.2013.11.018","journal-title":"Med Hypotheses"},{"issue":"1","key":"3086_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F, Hao F, Murray IA, Smith PB, Koo I, Tindall AM, Kris-Etherton PM, Gowda K, Amin SG, Patterson AD, Perdew GH (2020) Intestinal microbiota-derived tryptophan metabolites are predictive of ah receptor activity. Gut Microbes 12(1):1\u201324. https:\/\/doi.org\/10.1080\/19490976.2020.1788899","journal-title":"Gut Microbes"},{"key":"3086_CR20","doi-asserted-by":"publisher","unstructured":"DSM-V: Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, Fifth (2013) Am Psychiatr Assoc\u00a0https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"2","key":"3086_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jcpp.12899","volume":"60","author":"SV Faraone","year":"2019","unstructured":"Faraone SV, Rostain AL, Blader J, Busch B, Childress AC, Connor DF, Newcorn JH (2019) Practitioner review: emotional dysregulation in attention-deficit\/hyperactivity disorder\u2014implications for clinical recognition and intervention. J Child Psychol Psychiatry 60(2):133\u2013150. https:\/\/doi.org\/10.1111\/jcpp.12899","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"3086_CR22","doi-asserted-by":"publisher","first-page":"17799","DOI":"10.1038\/srep17799","volume":"5","author":"F Fazio","year":"2015","unstructured":"Fazio F, Lionetto L, Curto M, Iacovelli L, Cavallari M, Zappulla C, Ulivieri M, Napoletano F, Capi M, Corigliano V, Scaccianoce S, Caruso A, Miele J, De Fusco A, Di Menna L, Comparelli A, De Carolis A, Gradini R, Nistic\u00f2 R, Simmaco M (2015) Xanthurenic acid activates mGlu2\/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia. Sci Rep 5(1):17799. https:\/\/doi.org\/10.1038\/srep17799","journal-title":"Sci Rep"},{"issue":"11","key":"3086_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/JAMA.2021.2104","volume":"325","author":"A Flanagin","year":"2021","unstructured":"Flanagin A, Frey T, Christiansen SL, Bauchner H (2021) The reporting of race and ethnicity in medical and science journals: comments invited. JAMA 325(11):1049\u20131052. https:\/\/doi.org\/10.1001\/JAMA.2021.2104","journal-title":"JAMA"},{"issue":"3","key":"3086_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao K, Mu C-L, Farzi A, Zhu W-Y (2020) Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr (Bethesda Md) 11(3):709\u2013723. https:\/\/doi.org\/10.1093\/advances\/nmz127","journal-title":"Adv Nutr (Bethesda Md)"},{"issue":"1","key":"3086_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-016-0109-5","volume":"7","author":"F Gevi","year":"2016","unstructured":"Gevi F, Zolla L, Gabriele S, Persico AM (2016) Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol Autism 7(1):47. https:\/\/doi.org\/10.1186\/s13229-016-0109-5","journal-title":"Mol Autism"},{"issue":"8","key":"3086_CR26","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. FEBS J 279(8):1356\u20131365. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08485.x","journal-title":"FEBS J"},{"key":"3086_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.70071","author":"HC Gustafsson","year":"2025","unstructured":"Gustafsson HC, Wright HR, Schreeder JEJ, Nigg JT, Sullivan EL (2025) Gestational kynurenine metabolites mediate effects of pregnancy adiposity on child negative affect. J Child Psychol Psychiatry Allied Discip. https:\/\/doi.org\/10.1111\/jcpp.70071","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"issue":"1","key":"3086_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez C, Quintana FJ (2018) Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48(1):19\u201333. https:\/\/doi.org\/10.1016\/j.immuni.2017.12.012","journal-title":"Immunity"},{"key":"3086_CR29","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65\u201370","journal-title":"Scand J Stat"},{"key":"3086_CR30","volume-title":"DRI Dietary Reference Intakes: Applications in Dietary Assessment","author":"Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes","year":"2000","unstructured":"Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes, Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (2000) Using the Tolerable Upper Intake Level for Nutrient Assessment of Groups. DRI Dietary Reference Intakes: Applications in Dietary Assessment. National Academics Press"},{"key":"3086_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2021.04.020","volume":"96","author":"F Javelle","year":"2021","unstructured":"Javelle F, Bloch W, Knoop A, Guillemin GJ, Zimmer P (2021) Toward a neuroprotective shift: eight weeks of high intensity interval training reduces the neurotoxic kynurenine activity concurrently to impulsivity in emotionally impulsive humans \u2013 a randomized controlled trial. Brain Behav Immun 96:7\u201317. https:\/\/doi.org\/10.1016\/j.bbi.2021.04.020","journal-title":"Brain Behav Immun"},{"key":"3086_CR32","doi-asserted-by":"publisher","DOI":"10.5334\/jcr.215","volume":"19","author":"BS Jim\u00e9nez-Z\u00e1rate","year":"2021","unstructured":"Jim\u00e9nez-Z\u00e1rate BS, Pi\u00f1a-Leyva C, Rodr\u00edguez-S\u00e1nchez M, Flor\u00e1n-Gardu\u00f1o B, Jim\u00e9nez-Zamudio LA, Jim\u00e9nez-Estrada I (2021) Day-night variations in the concentration of neurotransmitters in the rat lumbar spinal cord. J Circadian Rhythms 19:9. https:\/\/doi.org\/10.5334\/jcr.215","journal-title":"J Circadian Rhythms"},{"key":"3086_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2019.100478","author":"JM Johnstone","year":"2019","unstructured":"Johnstone JM, Leung B, Gracious B, Perez L, Tost G, Savoy A, Hatsu I, Hughes A, Bruton A, Arnold LE (2019) Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: the micronutrients for ADHD in youth (MADDY) study. Contemp Clin Trials Commun. https:\/\/doi.org\/10.1016\/j.conctc.2019.100478","journal-title":"Contemp Clin Trials Commun"},{"issue":"5","key":"3086_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jaac.2021.07.005","volume":"61","author":"JM Johnstone","year":"2022","unstructured":"Johnstone JM, Hatsu I, Tost G, Srikanth P, Eiterman LP, Bruton AM, Ast HK, Robinette LM, Stern MM, Millington EG, Gracious BL, Hughes AJ, Leung BMY, Arnold LE (2022) Micronutrients for attention-deficit\/hyperactivity disorder in youths: a placebo-controlled randomized clinical trial. J Am Acad Child Adolesc Psychiatry 61(5):647\u2013661. https:\/\/doi.org\/10.1016\/j.jaac.2021.07.005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"3086_CR36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jaac.2023.07.994","volume":"62","author":"JM Johnstone","year":"2023","unstructured":"Johnstone JM, Arnold LE, Villagomez A, Robinette LM, Gracious BL, Ast HK, Bruton AM, Hatsu IE (2023) Dr. Johnstone et al. reply to Dr. Elmrayed. J Am Acad Child Adolesc Psychiatry 62(11):1171\u20131175. https:\/\/doi.org\/10.1016\/j.jaac.2023.07.994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3086_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/bcp.70014","author":"BM Kew","year":"2025","unstructured":"Kew BM, Doogue MP, McNeill R, Zhang M, Rucklidge JJ, Frampton CM, Mulder RT, Beaglehole B (2025) Investigation of a broad-spectrum micronutrient formulation as a possible precipitant of pharmacokinetic micronutrient\u2013drug interactions. Br J Clin Pharmacol. https:\/\/doi.org\/10.1002\/bcp.70014","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3086_CR38","first-page":"243","volume":"34","author":"A Kusaga","year":"2002","unstructured":"Kusaga A (2002) Decreased beta-phenylethylamine in urine of children with attention deficit hyperactivity disorder and autistic disorder]. No To Hattatsu 34(3):243\u2013248","journal-title":"No To Hattatsu"},{"issue":"3","key":"3086_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ANA.10302","volume":"52","author":"A Kusaga","year":"2002","unstructured":"Kusaga A, Yamashita Y, Koeda T, Hiratani M, Kaneko M, Yamada S, Matsuishi T (2002) Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Ann Neurol 52(3):372\u2013374. https:\/\/doi.org\/10.1002\/ANA.10302","journal-title":"Ann Neurol"},{"issue":"1","key":"3086_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00109-016-1486-0","volume":"95","author":"HU Lee","year":"2017","unstructured":"Lee HU, McPherson ZE, Tan B, Korecka A, Pettersson S (2017) Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system. J Mol Med 95(1):29\u201339. https:\/\/doi.org\/10.1007\/s00109-016-1486-0","journal-title":"J Mol Med"},{"key":"3086_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-023-02236-2","author":"BMY Leung","year":"2023","unstructured":"Leung BMY, Srikanth P, Robinette L, Bruton AM, Tost G, Hatsu I, Arnold LE, Johnstone JM (2023) Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension. Eur Child Adolesc Psychiatry. https:\/\/doi.org\/10.1007\/s00787-023-02236-2","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3086_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00552","author":"H Liu","year":"2018","unstructured":"Liu H, Ding L, Zhang H, Mellor D, Wu H, Zhao D, Wu C, Lin Z, Yuan J, Peng D (2018) The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2018.00552","journal-title":"Front Psychiatry"},{"key":"3086_CR43","doi-asserted-by":"publisher","unstructured":"Loftis J, Ast HK, Srikanth P, Ramesh R, Bruton AM, Machingo TA, Hatsu IE, Robinette LM, Arnold LE, Erikson D, Johnstone JM (2025) Multinutrient supplementation in children with ADHD reduced pro- and anti-inflammatory immune factors in the MADDY randomized control trial. https:\/\/doi.org\/10.1177\/10870547251397701","DOI":"10.1177\/10870547251397701"},{"key":"3086_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s41252-024-00433-x","author":"TA Machingo","year":"2024","unstructured":"Machingo TA, Bruton AM, Ryan JJ, Johnstone JM (2024) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in ADHD: a systematic scoping review. Adv Neurodev Disord. https:\/\/doi.org\/10.1007\/s41252-024-00433-x","journal-title":"Adv Neurodev Disord"},{"issue":"1","key":"3086_CR45","first-page":"3","volume":"67","author":"M Majewski","year":"2016","unstructured":"Majewski M, Kozlowska A, Thoene M, Lepiarczyk E, Grzegorzewski WJ (2016) Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease. J Physiol Pharmacol 67(1):3\u201319","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"3086_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/J.JAAC.2013.11.013","volume":"53","author":"RHB Mitchell","year":"2014","unstructured":"Mitchell RHB, Goldstein BI (2014) Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry 53(3):274\u2013296. https:\/\/doi.org\/10.1016\/J.JAAC.2013.11.013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"3086_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/J.JPSYCHIRES.2012.09.020","volume":"47","author":"A Molina-Carballo","year":"2013","unstructured":"Molina-Carballo A, Naranjo-G\u00f3mez A, Uberos J, Justicia-Mart\u00ednez F, Ruiz-Ramos MJ, Cubero-Mill\u00e1n I, Contreras-Chova F, Augustin-Morales MdelC, Khaldy-Belkadi H, Mu\u00f1oz-Hoyos A (2013) Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD. J Psychiatr Res 47(3):377\u2013383. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2012.09.020","journal-title":"J Psychiatr Res"},{"key":"3086_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/J.PSYCHRES.2021.114060","author":"A Molina-Carballo","year":"2021","unstructured":"Molina-Carballo A, Cubero-Mill\u00e1n I, Fern\u00e1ndez-L\u00f3pez L, Checa-Ros A, Machado-Casas I, Jerez-Calero A, Blanca-Jover E, Cantarero-Malag\u00f3n AM, Uberos J, Mu\u00f1oz-Hoyos A (2021) Methylphenidate ameliorates the homeostatic balance between levels of kynurenines in ADHD children. Psychiatr Res. https:\/\/doi.org\/10.1016\/J.PSYCHRES.2021.114060","journal-title":"Psychiatr Res"},{"issue":"8","key":"3086_CR49","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00216-011-5322-7","volume":"401","author":"M Moriarty","year":"2011","unstructured":"Moriarty M, Lee A, O\u2019Connell B, Kelleher A, Keeley H, Furey A (2011) Development of an LC-MS\/MS method for the analysis of serotonin and related compounds in urine and the identification of a potential biomarker for attention deficit hyperactivity\/hyperkinetic disorder. Anal Bioanal Chem 401(8):2481\u20132493. https:\/\/doi.org\/10.1007\/s00216-011-5322-7","journal-title":"Anal Bioanal Chem"},{"key":"3086_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.schres.2020.09.007","volume":"223","author":"M Morrens","year":"2020","unstructured":"Morrens M, De Picker L, Kampen JK, Coppens V (2020) Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: a meta-analysis. Schizophr Res 223:43\u201352. https:\/\/doi.org\/10.1016\/j.schres.2020.09.007","journal-title":"Schizophr Res"},{"issue":"1","key":"3086_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0166-4328(97)02306-1","volume":"88","author":"RD Oades","year":"1997","unstructured":"Oades RD, M\u00fcller B (1997) The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis. Behav Brain Res 88(1):95\u2013102. https:\/\/doi.org\/10.1016\/S0166-4328(97)02306-1","journal-title":"Behav Brain Res"},{"key":"3086_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24066010","author":"ML Pais","year":"2023","unstructured":"Pais ML, Martins J, Castelo-Branco M, Gon\u00e7alves J (2023) Sex differences in tryptophan metabolism: a systematic review focused on neuropsychiatric disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24066010","journal-title":"Int J Mol Sci"},{"key":"3086_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084385","author":"E Predescu","year":"2024","unstructured":"Predescu E, Vaidean T, Rapciuc A-M, Sipos R (2024) Metabolomic markers in attention-deficit\/hyperactivity disorder (ADHD) among children and adolescents\u2014a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25084385","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3086_CR54","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1038\/s41380-020-0645-4","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, Chen X, Chen Y, Yang L, Ran Y, Zhong X, Xu S, Song X, Liu L, Zheng P, Wang H, Xie P (2021) An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry 26(8):4265\u20134276. https:\/\/doi.org\/10.1038\/s41380-020-0645-4","journal-title":"Mol Psychiatry"},{"key":"3086_CR55","unstructured":"R & Foundation for Statistical Computing (2022) R: A language and environment for statistical computing. (Version 4.2.2) [Computer software]. R Core Team. https:\/\/www.R-project.org\/"},{"key":"3086_CR56","doi-asserted-by":"crossref","unstructured":"Robinette LM, Hatsu IE, Olorufemi A, Wu C-M, Johnsone JM, Bruton AM, Ast HK, Odei J, Ziouzenkova O, Leung BMY, Arnold LE (2025) Multinutrients decrease oxidative stress in children with ADHD: Mediation\/ moderation analysis of randomized controlled trial data. Jour Atten Dis, 29(10)","DOI":"10.1177\/10870547251355998"},{"key":"3086_CR57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1192\/bjp.bp.113.132126","volume":"204","author":"JJ Rucklidge","year":"2014","unstructured":"Rucklidge JJ, Frampton CM, Gorman B, Boggis A (2014) Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 204:306\u2013315. https:\/\/doi.org\/10.1192\/bjp.bp.113.132126","journal-title":"Br J Psychiatry"},{"issue":"3","key":"3086_CR58","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jcpp.12817","volume":"59","author":"JJ Rucklidge","year":"2018","unstructured":"Rucklidge JJ, Eggleston MJF, Johnstone JM, Darling K, Frampton CM (2018) Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial. J Child Psychol Psychiatry 59(3):232\u2013246. https:\/\/doi.org\/10.1111\/jcpp.12817","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"3086_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0306-4522(92)90467-g","volume":"51","author":"K Saito","year":"1992","unstructured":"Saito K, Markey SP, Heyes MP (1992) Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 51(1):25\u201339. https:\/\/doi.org\/10.1016\/0306-4522(92)90467-g","journal-title":"Neuroscience"},{"key":"3086_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112:237\u2013247","journal-title":"Neuropharmacology"},{"issue":"7","key":"3086_CR61","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13(7):465\u2013477. https:\/\/doi.org\/10.1038\/nrn3257","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"3086_CR62","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1176\/appi.ajp.2013.13070966","volume":"171","author":"P Shaw","year":"2014","unstructured":"Shaw P, Stringaris A, Nigg J, Leibenluft E (2014) Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry 171(3):276\u2013293. https:\/\/doi.org\/10.1176\/appi.ajp.2013.13070966","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3086_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/fsn3.3787","volume":"12","author":"VV Sugandhi","year":"2024","unstructured":"Sugandhi VV, Pangeni R, Vora LK, Poudel S, Nangare S, Jagwani S, Gadhave D, Qin C, Pandya A, Shah P, Jadhav K, Mahajan HS, Patravale V (2024) Pharmacokinetics of vitamin dosage forms: a complete overview. Food Sci Nutr 12(1):48\u201383. https:\/\/doi.org\/10.1002\/fsn3.3787","journal-title":"Food Sci Nutr"},{"issue":"10","key":"3086_CR64","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/10408398.2019.1598334","volume":"60","author":"M Sun","year":"2020","unstructured":"Sun M, Ma N, He T, Johnston LJ, Ma X (2020) Tryptophan (Trp) modulates gut homeostasis via Aryl hydrocarbon receptor (AhR). Crit Rev Food Sci Nutr 60(10):1760\u20131768. https:\/\/doi.org\/10.1080\/10408398.2019.1598334","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"16","key":"3086_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162607","volume":"11","author":"M Tanaka","year":"2022","unstructured":"Tanaka M, Szab\u00f3 \u00c1, Spekker E, Poly\u00e1k H, T\u00f3th F, V\u00e9csei L (2022) Mitochondrial impairment: a common motif in neuropsychiatric presentation? The link to the tryptophan\u2013kynurenine metabolic system. Cells 11(16):16. https:\/\/doi.org\/10.3390\/cells11162607","journal-title":"Cells"},{"issue":"6","key":"3086_CR66","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/HUP.513","volume":"18","author":"MG Uzbekov","year":"2003","unstructured":"Uzbekov MG, Misionzhnik EY (2003) Changes in urinary monoamine excretion in hyperkinetic children. Hum Psychopharmacol: Clin Exp 18(6):493\u2013497. https:\/\/doi.org\/10.1002\/HUP.513","journal-title":"Hum Psychopharmacol: Clin Exp"},{"issue":"3","key":"3086_CR67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","volume":"34","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele TJ (2019) Principles of confounder selection. Eur J Epidemiol 34(3):211\u2013219. https:\/\/doi.org\/10.1007\/s10654-019-00494-6","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"3086_CR68","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1176\/AJP.127.10.1411","volume":"127","author":"PH Wender","year":"1971","unstructured":"Wender PH, Epstein RS, Kopin IJ, Gordon EK (1971) Urinary monoamine metabolites in children with minimal brain dysfunction. Am J Psychiatry 127(10):1411\u20131415. https:\/\/doi.org\/10.1176\/AJP.127.10.1411","journal-title":"Am J Psychiatry"},{"issue":"3","key":"3086_CR69","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/ARCHPSYC.1985.01790260045005","volume":"42","author":"AJ Zametkin","year":"1985","unstructured":"Zametkin AJ, Karoum F, Linnoila M, Rapoport JL, Brown GL, Chuang LW, Wyatt RJ (1985a) Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine. Arch Gen Psychiatry 42(3):251\u2013255. https:\/\/doi.org\/10.1001\/ARCHPSYC.1985.01790260045005","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"3086_CR70","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/ARCHPSYC.1985.01790330049006","volume":"42","author":"A Zametkin","year":"1985","unstructured":"Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D (1985b) Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment. Arch Gen Psychiatry 42(10):969\u2013973. https:\/\/doi.org\/10.1001\/ARCHPSYC.1985.01790330049006","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"3086_CR71","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1176\/AJP.143.3.359","volume":"143","author":"AJ Zametkin","year":"1986","unstructured":"Zametkin AJ, Linnoila M, Karoum F, Sallee R (1986) Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder. Am J Psychiatry 143(3):359\u2013362. https:\/\/doi.org\/10.1176\/AJP.143.3.359","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03086-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:07:44Z","timestamp":1785600464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03086-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Arnold has received research funding from Axial, Forest, Lilly, Noven, Otsuka, Shire, Supernus, Roche, Yamo, Maplight and YoungLiving (as well as NIH and Autism Speaks); has consulted with Pfizer, Tris Pharma, and Waypoint and been on advisory boards for Arbor, Ironshore, Otsuka, Pfizer, Roche, Seaside Therapeutics and Shire. Dr. Bruton is a part-time employee of and conducted some work for this publication on behalf of ZRT Laboratory, a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by OHSU. Dr. Zava has a financial interest in ZRT Laboratory, a company that may have a commercial interest in the results of this research and technology. The other authors have no disclosures or conflict of interest to report.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}